A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : RANK

Search Conditions:
Search Keyword : RANK
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: RANK
Appearance Frequency: 853 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
receptor activator of NF-kappaB
(832 times)
Neoplasms
(92 times)
RANKL (332 times)
OPG (263 times)
TRAP (61 times)
1998 Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.
ranked according to their competitive season performance
(2 times)
Sports Medicine
(2 times)
ECON (1 time)
ELS (1 time)
LT (1 time)
2001 Physiological determinants of cross-country ski racing performance.
RANKL receptor
(2 times)
Science
(1 time)
2MD (1 time)
CSF-1 (1 time)
CSF-1R (1 time)
2012 Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.
RANKL, its receptor
(2 times)
Medicine
(2 times)
MSC (1 time)
NF-kB (1 time)
OPG (1 time)
2016 Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.
(RANKL)-receptor-activator of nuclear kappaB
(1 time)
Clinical Laboratory Techniques
(1 time)
ABC (1 time)
GCTB (1 time)
RANKL (1 time)
2014 Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response.
RANK ligand
(1 time)
Metabolism
(1 time)
ASBMR (1 time)
OPG (1 time)
TNF (1 time)
2000 Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature.
RANK-Fc
(1 time)
Orthopedics
(1 time)
OI (1 time)
WT (1 time)
2008 The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta.
RANKL activity is balanced by interaction with its receptor
(1 time)
Hematology
(1 time)
beta-TM (1 time)
DFO (1 time)
EC (1 time)
2010 Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density.
RANKL and RANKL receptor
(1 time)
Pharmacology
(1 time)
AR (1 time)
OVA (1 time)
RANKL (1 time)
2019 An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammation.
10  RANKL interactions with its activator
(1 time)
Antineoplastic Agents
(1 time)
RANKL (1 time)
2008 Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorption.
11  RANKL-dependent
(1 time)
Traumatology
(1 time)
M-CSF (1 time)
RANKL (1 time)
SAM (1 time)
2006 Staphylococcus aureus capsular material promotes osteoclast formation.
12  RANKL-suppression of its own signaling receptor
(1 time)
Biology
(1 time)
RANKL (1 time)
2009 The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse.
13  RANKmko
(1 time)
OPG (1 time)
2016 Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction.
14  ranks based on family mean values of two traits
(1 time)
Genetics
(1 time)
BLUPs (1 time)
PROB (1 time)
1992 Estimating the potential of sugarcane families to produce elite genotypes using bivariate prediction methods.
15  Receptor activator of nuclear factor kappa-light-chain-enhancer of activated B-cells
(1 time)
Neoplasms
(1 time)
TNF (1 time)
2010 RANK ligand: effects of inhibition.
16  Receptor Activator of Nuclear Transcription Factor NF-kappaB
(1 time)
Biology
(1 time)
OPG (1 time)
2017 Receptor Activator of Nuclear Transcription Factor NF-kappaB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors.
17  receptor for the Receptor of NF-kappaB
(1 time)
General Surgery
(1 time)
mTOR (1 time)
OPG (1 time)
2013 Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model.
18  receptor gene NF - kappa ss
(1 time)
Orthopedic Procedures
(1 time)
PGE2 (1 time)
2004 Role of interleukin-17 in cartilage and bone destruction in rheumatoid arthritis.
19  Receptors of NFkappaB
(1 time)
Biochemistry
(1 time)
BMP (1 time)
TGF (1 time)
TNF (1 time)
2012 Inhibition of osteoclast generation: a novel function of the bone morphogenetic protein 7/osteogenic protein 1.